Corient Private Wealth
HUMAW icon

Corient Private Wealth’s Humacyte Inc Warrant HUMAW Stock Holding History

Corient Private Wealth’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$18K – 2427
2024
Q3 		$18K Buy
+10,000
New +$22K ﹤0.01% 2432

Other funds holding HUMAW

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Corient Private Wealth's HUMAW Position: Q4 2024 in Review

Corient Private Wealth sold out of Humacyte Inc Warrant (HUMAW) in Q4 2024, closing a stake of 10,000 shares — an estimated $18K sold.

Corient Private Wealth first reported a position in HUMAW in Q3 2024 and held it in 1 quarter. The position peaked at $18K in Q3 2024. 5 funds tracked by Wall St. Rank hold HUMAW as of Q4 2024.

  • Corient Private Wealth reported no remaining Humacyte Inc Warrant position as of Q4 2024 after selling out during the quarter.
  • Corient Private Wealth sold 10,000 Humacyte Inc Warrant shares in Q4 2024, an estimated $18K.
  • Corient Private Wealth first reported a position in Humacyte Inc Warrant in Q3 2024 and held it in 1 quarter.
  • Corient Private Wealth's Humacyte Inc Warrant position peaked at $18K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q4 2024.

Based on Corient Private Wealth's 13F filing for Q4 2024, filed 10 Feb 2025.